Jefferies served as Joint Financial Advisor on the multi-billion-dollar pending acquisition of Organon valued at $11.75 billion, driving long-term strategic positioning across global commercial therapeutics and specialty pharmaceuticals.
| Sector | Healthcare / Specialty Therapeutics |
| Transaction Value | $11,750,000,000 |
| Jefferies Role | Joint Financial Advisor |
| Status | Pending |
